A rare, primary immunodeficiency. It is caused by a currently undetermined defect in the Fas-induced apoptosis pathway. No mutations in Fas, FASLG or CASP10 are detectable. Disruption of Fas-induced apoptosis impairs lymphocyte homeostasis and immune tolerance. Characteristic laboratory findings include an increase in circulating, double-negative (CD4-/CD8-) T cells in the setting of immune-mediated anemia, thrombocytopenia and neutropenia. Clinical signs present in childhood include fatigue, pallor, bruising, hepatosplenomegaly and chronic, non-malignant, non-infectious lymphadenopathy. The clinical course is influenced by a strong association with other autoimmune disorders and an increased risk for developing Hodgkin and non-Hodgkin lymphoma.
Comprehensive, easy-to-understand information about this condition
Checking for content...
No external resources available.
autoimmune lymphoproliferative syndrome type 1
MONDO:0011158
autoimmune lymphoproliferative syndrome type 2A
MONDO:0011383
autoimmune lymphoproliferative syndrome type 2B
MONDO:0011804
autoimmune lymphoproliferative syndrome type 4
MONDO:0013767
autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency
MONDO:0014493
Castleman-Kojima disease
MONDO:0018702